STAT1 and gastric cancer: In summary, we showed that IL-26 promotes cell growth and prevents apoptosis of human gastric cancer cells by modulating the balance of STAT1/STAT3 signaling, indicating that IL-26 may be a valuable prognostic indicator and therapeutic target in gastric cancer patients.